Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle movement therapy may help preterm babies at risk of cerebral palsy

NCT ID NCT07449312

Disease control Sponsor: University of Zurich Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new therapy for preterm babies born before 32 weeks who show abnormal general movements, a sign of possible developmental problems like cerebral palsy. The therapy involves gently guiding the baby's stiff or cramped movements into more normal, fluid patterns. Researchers will compare 40 babies receiving this therapy plus usual care with 40 babies receiving usual care alone, measuring motor skills at 3 months and 2 years of age.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Movement Imitation Therapy (manual guidance of movements)
What this could lead to
If it works, this therapy could help preterm babies at risk of cerebral palsy develop better motor skills and reduce long-term disability.
What could go wrong
This is a small pilot study with only 80 babies, so results may not apply to all preterm infants. The therapy requires active parent involvement, which may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2023

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

23 to 32 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm infants * Gestational age \< 32 weeks * GMOS ≤ 23/42 at 33 0/7 - 34 6/7 weeks PMA * General medical condition stable to the extent that video imaging of the GMs in supine position is possible (minimal underpinning and non-invasive ventilation or oxygen support are allowed) * Hospitalisation at the NICU at University Hospital Zurich (USZ) or Inselspital Bern * Place of residence located in order to ensure appropriate follow-up outpatient physiotherapy treatment, if indicated * Parent or legal guardian must be able to give informed consent as documented by signature Exclusion Criteria: * Syndromal disease * Neuromuscular disease (e.g. myelomeningocele, spinal muscular atrophy) * Underlying musculoskeletal disease (e.g. arthrogryposis, clubfoot) * Participation in other studies if it is anticipated that the interventions in each case could affect the outcome of the other study * Inability of the legal guardian to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Early intervention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Early intervention General movements Preterm birth

Contacts and locations

Locations

  • University Hospital Zurich

    Zurich, Canton of Zurich, 8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.